Advanced Search
Contact | Corporate | Help

Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)

Sponsors:
  • Translational Oncology Research International
  • Genentech
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: Bevacizumab (drug), Herceptin (drug)
Enrollment:
50

Additional information about NCT00095706.


SourceSolution © 2008-2012